Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
88.8 EUR | +0.71% | +1.97% | -1.40% |
07:45am | Sanofi Reports Positive Results from Phase 3 Trial of Rilzabrutinib for Immune Thrombocytopenia | MT |
07:39am | Sanofi Says Blood-Disorder Drug Meets Key Target in Late-Stage Trial | DJ |
Filters
- Stock Market
- Equities
- SAN Stock
- News Sanofi